Header Logo

Connection

YESID ALVARADO to Proportional Hazards Models

Back to Details
This is a "connection" page, showing publications YESID ALVARADO has written about Proportional Hazards Models.
YESID ALVARADO
Connection Strength
0.021
Proportional Hazards Models
  1. Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study. Lancet Oncol. 2018 02; 19(2):240-248.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.